ICHNOS GLENMARK INNOVATION
GLOBAL PRESENCE
  • US
  • INDIA
  • EUROPE
  • LATINA AMERICA
  • ROW
    • ASIA
      • MALAYSIA
    • ME & AFRICA
    • RUSSIA & CIS
CONTACT US
FOLLOW US
  • About Us

    About US

    Evolution

    The achievements that highlight our journey

    Governance

    The tenants of our funtioning

    Borad of Directors

    The people who pave the way for a new world

    Executive Team

    The Team who translates vision into reality

    Awards

    Striving for Excellance

  • Innovation

    Innovation

    Our Innovation Journey

    Centers of Innovation

    Pipeline

  • Products

    Products

    Formulations

    High quality branded and
    generic medicines for global markets

    Overview
    Global Presense +

    Quality at Glenmark
    Manufacturing Facilities
    Business Development

  • Responsibility

    Responsibility

    Our Communities

    Enriching lives for a healthier and
    happier world

    Our Planet

    Operating responsibly towards a greener
    planet

    Our People

    The people who pave the way for a new world

    Child Health

    Access to Health Care

    Promotion of Sports

    Sustainable Livelihoods

    Glenmark Joy of Giving

    Water Conservation and Mgmt

    Impact Accessment Reports

    Support during Covid-19

    Our Communities

    Enriching lives for a healthier and

    happier world

    Reports

    Our Sustainability Reports

    FY 2024 FY 2023 FY 2022

    more

    Equal Opportunity for all

    Employee Health and Safety

    Foundations

    Spearheading our social initiatives

    Glenmark Foundation

    Glenmark Aquatic Foundation

  • Investors

    Investors

    Reports and Presentations

    Performance in numbers

    Latest Announcements

    For Investors and Shareholders

    Financial Results

    Growing Strenth to Strenth

    ESG Profile

    Our Environment, Social & Governance initiatives

    ESG Profile

    Our Environment, Social & Governance initiatives

    Disclosures under Regulation 46

    Pursuant to SEBI LODR

  • Careers

    Investors

    Life at Glenmark

    Join Us

  • Media

    Investors

    Newsroom

    Latest and archived press releases

☰ Menu

Integrated Report is now live

We are pleased to present Glenmark Pharmaceuticals Limited’s third Integrated Report for FY 2024

A NEW WAY FOR A NEW WORLD

At Glenmark, we believe in enriching lives and making a difference to patients all over the world. We constantly strive to find new ways that pave the way for a healthier tomorrow.

DISCOVERING ADVANCE THERAPIES FOR A NEW WORLD

We are creating centers of excellence in dermatology, oncology and respiratory therapy. The effort is to develop advance therapies to enrich the lives of patients worldwide.

A NEW WORLD.
A HEALTHIER WORLD.

We are pleased to present Glenmark Pharmaceuticals Limited’s third Integrated Report for FY 2024

A NEW WAY FOR A NEW WORLD BEGINS WITH US

Employees based out of 50+ offices all over the world working towards one mission - Enriching lives globally.

INVESTOR CORNER

ANNOUNCEMENTS

First Results of a Phase 1, First-in
-Human, Dose Escalation Study of ISB
2001, a BCMAxCD38xCD3 Targeting
Trispecific Antibody in Patients with
Relapsed/Refractory Multiple Myeloma
(RRMM)

invest-Logo
news_announcement

JAN 21, 2025

NEWS ANNOUNCEMENT

Glenmark Pharmaceuticals Inc., USA
launches Phytonadione Injectable
Emulsion USP, 10 mg/mL Single Dose
Ampules

CAREERS

Glenmark is a leading, research–based
global pharmaceutical company

careers_thumbnail